Faculty Disclosures
| Thomas P. Bleck, MD, FAAN |
Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. Dr. Bleck has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for iECURE. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acasti. Dr. Bleck has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Society of Critical Care Medicine. Dr. Bleck has received research support from NIH. |
| Stewart A. Factor, DO, FAAN |
Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Factor has received research support from Biohaven. The institution of Dr. Factor has received research support from Voyager. The institution of Dr. Factor has received research support from Neurocrine. The institution of Dr. Factor has received research support from Supernus. The institution of Dr. Factor has received research support from Prelinia. The institution of Dr. Factor has received research support from Medtronics. The institution of Dr. Factor has received research support from Boston Scientific. The institution of Dr. Factor has received research support from Sun Pharmaceuticals Advanced Research Company. The institution of Dr. Factor has received research support from Aspen. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. |
| Hector R. Martinez, MD |
No disclosure on file
|
| Peter A. Calabresi, MD, FAAN |
Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME. |
| Nestor Galvez-Jimenez, MD |
Dr. Galvez-Jimenez has nothing to disclose. |
| Aksel Siva, MD |
Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ali Raif Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanovel Pharmaceuticals, Turkiye. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abdi Ibrahim Ilac - TR. Dr. Siva has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono . The institution of Dr. Siva has received research support from Turkish MS Society. The institution of Dr. Siva has received research support from The Scientific and Technological Research Council Of Turkey - Health Sciences Research Grants. |
| Andrea Hidalgo, MD |
Dr. Hidalgo has nothing to disclose. |
|
No disclosure on file
|
| Pablo Villoslada, MD, PhD, FAAN |
Dr. Villoslada has received personal compensation for serving as an employee of Attune Neuroscience. Dr. Villoslada has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Accure Therapeutics. Dr. Villoslada has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oculis. Dr. Villoslada has stock in Attune Neurosciences. Dr. Villoslada has stock in Bionure Investments. Dr. Villoslada has stock in Spiral Therapeutics. Dr. Villoslada has stock in Adhera Health. The institution of Dr. Villoslada has received research support from Start2Cure Foundation. The institution of Dr. Villoslada has received research support from NIH. The institution of Dr. Villoslada has received research support from Department of Defense. Dr. Villoslada has received intellectual property interests from a discovery or technology relating to health care. |
| Amer Alshekhlee, MD |
No disclosure on file
|
| Jawad F. Kirmani, MD |
Dr. Kirmani has nothing to disclose. |
| Shyam Prabhakaran, MD |
Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. The institution of Dr. Prabhakaran has received research support from NIH . The institution of Dr. Prabhakaran has received research support from AHRQ. Dr. Prabhakaran has received publishing royalties from a publication relating to health care. |
| Richard E. Temes, MD |
No disclosure on file
|
| Vivien H. Lee, MD, FAAN |
Dr. Lee has nothing to disclose. |
| Fadi B. Nahab, MD |
Dr. Nahab has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Consultation. Dr. Nahab has received intellectual property interests from a discovery or technology relating to health care. |
| Tarannum Khan, MD, MBBS, FAAN |
Dr. Khan has nothing to disclose. |
| Karen C. Albright, DO, DO, PhD, MS, MPH |
Dr. Albright has nothing to disclose. |
| Sayona John, MD, FAAN |
Dr. John has nothing to disclose. |
| Nirav Vora, MD |
No disclosure on file
|
| Sheryl Martin-Schild, MD, PhD, FAAN |
No disclosure on file
|
| Rajeev Garg, MD, FAAN |
No disclosure on file
|
| Akram Shhadeh, MD, MBA |
No disclosure on file
|
| Jai Perumal, MD |
Dr. Perumal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Perumal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for T G therapeutics. Dr. Perumal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. |
| James Conners, MD |
The institution of Dr. Conners has received research support from nih. |
| Ankur Garg, MD |
Dr. Garg has nothing to disclose. |
| Frank Bennett, PhD |
No disclosure on file
|
| Mohammad Moussavi, MD |
Dr. Moussavi has nothing to disclose. |
| Luis Espinosa, MD |
No disclosure on file
|
| Scott Saucedo, MD |
No disclosure on file
|
| Sonal Mehta, MD |
Dr. Mehta has nothing to disclose. |
| Shiv Saidha, MD |
Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReWind Therapeutics. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Pharmaceuticals. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Saidha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Saidha has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Multiple Sclerosis Journal ETC. Dr. Saidha has stock in June Brain. Dr. Saidha has stock in Lapix Therapeutics. The institution of Dr. Saidha has received research support from Biogen. The institution of Dr. Saidha has received research support from Genentech. The institution of Dr. Saidha has received research support from Novartis. The institution of Dr. Saidha has received research support from Lapix Therapeutics. The institution of Dr. Saidha has received research support from Novartis. |
| Muhib Khan, MD, FAAN |
The institution of Dr. Khan has received research support from Mayo Clinic 好色先生 Grant . The institution of Dr. Khan has received research support from Mayo Clinic Small Grants . |
| Haitham Dababneh, MD |
No disclosure on file
|
| Amy L. Phillips, PharmD |
Amy L. Phillips, PharmD has received personal compensation for serving as an employee of EMD Serono, Inc. |
| Dimitrios Giannakidis, MD |
Dr. Giannakidis has nothing to disclose. |
| John H. Barghols, MD |
No disclosure on file
|
| Hesham A. Allam, MD |
Dr. Allam has nothing to disclose. |
| Jiri Brabec, MD |
No disclosure on file
|
| Camilo I. Garcia-Gracia, MD |
Dr. Garcia-Gracia has received personal compensation for serving as an employee of jazz pharmaceutical. Dr. Garcia-Gracia has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz pharmaceutical. |
| Kumiko Owada, MD |
No disclosure on file
|
| Giovana Femat, MD |
No disclosure on file
|
| Dennys Reyes, MD |
No disclosure on file
|
| Shira McMahan, DO |
No disclosure on file
|
| Aws Alawi, MD |
No disclosure on file
|
| Andre Kumar |
No disclosure on file
|
| Amelia K. Boehme, PhD |
Dr. Boehme has nothing to disclose. |
| Nicole Ulrich |
No disclosure on file
|
| Juanzhi Fang |
No disclosure on file
|
| Chirag Gandhi |
Chirag Gandhi has nothing to disclose. |